Protocol 1: moderate weight loss (10-15% body weight) Goal: Steady, sustainable weight loss with minimal side effects Tirzepatide approach: Standard escalation to 5-7.5 mg Hold at the dose where you achieve consistent weekly loss of 0.5-1% body weight Expected timeline: 24-36 weeks to target Likely maintenance dose: 5-7.5 mg Retatrutide approach: Standard escalation to 4 mg 4 mg delivered 12.9% weight loss at 24 weeks in trials Hold at 4 mg if achieving target rate Expected timeline: 20-30 weeks to target For moderate goals, both compounds work well at their lower dose ranges
7 These pathways are shown in FIGURE 1
This metabolic slowdown makes continued weight loss increasingly difficult
if generics scale, retail math changes fast, and early projections suggest a dramatic drop in list-level pricing, for example, PURE Medical Spa, The introduction of generic versions could reduce prices by 50% . That kind of structural shift would alter how clinics set fees, how insurers think about coverage, and how long-term therapy is planned
Kidney stones arent usually a Ozempic issue, but they can co-occur
Excessive cytokine activity, including IL-1, IL-6, and TNF-, amplifies these alterations (Hughes et al